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Medical control of  abdominal aortic aneurysm 
expansion rate 
To the Editors: 
In the recently published article by Mohammed M. 
Moursi and colleagues, "Inhibition of aortic aneurysm 
devetopment in blotchy mice by beta adrenergic blockade 
independent of altered lysyl oxidase activity" (J Vase Surg 
1995 ;21:792 - 800), the authors extrapolated findings from 
the experimental mouse model to the commonly encoun- 
tered clinical situation of expanding abdominal aortic 
aneurysm (AAA). This article and previously reported 
experimental nd clinical studies have discussed various 
potential mechanisms to account for ~-blocker-related 
attenuation of AAA expansion. 1'2 However, this effect 
remains enigmatic, and several new aspects merit further 
comments. Recently we have demonstrated by in situ 
hybridization the expression ofplasminogen activator (PA) 
genes, namely, tissue type (t-PA) and urokinase type (u-PA), 
and plasminogen activator inhibitor type 1 (PAI-1) within 
macrophage-like cells ofinflammatory infiltrates within the 
wall oflarge AAAs. PA gene expression was colocalized with 
areas of neovascularization within the vascular wall, sug- 
gesting local angiogenesis in response to active pericellular 
fibrinolysis. Increased fibrinolytic capacity in AAA wall may 
also contribute to local proteolytic degradation ofthe aortic 
wall via plasmin generation and activation of metallopro- 
teinases. 30ur  findings support a previous report of in- 
creased PA production in AAA wall 4 and suggest a major 
role for plasminogen activators, assumed to initiate a 
cascade of events, leading to physical weakening of the 
vascular wall and active expansion of the aneurysm. Experi- 
mental and clinical data also have shown the ability of the 
[5-blocker propranolol to reduce plasma fibrinolytic activity 
by blocking circulating t-PA. s-7 It is therefore reasonable to
hypothesize a similar blocking effect on t-PA within the 
aneurysm wall. As treatment ofAAA patients with propra- 
nolol signifieantly slows the rate of aneurysm expansion, 1,2 
our suggested mechanism of PA inhibition may explain the 
observed eceleration effect of propranolol on AAA ex- 
pansion. 
Jacob Schneiderman, MD
Raphael Adar, MD 
Department ofGeneral and Vascular Surgery 
and the Gottesdiener Vascular Biology Laboratory 
Isaac Engelberg, MD 
Department ofPathology 
Sheba Medical Center 
Tel Aviv University, Israel 
Gerald M. Bordin, MD 
Department ofClinical Pathology 
Deitmar Seiffert, MD 
David J. Loskutoff, PhD 
Department ofVascular Biology 
Ralph B. Dilley, MD 
Division of Thoracic and Vascular Surgery 
Scripps Institutions of Medicine and Science 
La Jolla, CA 92037 
REFERENCES 
1. Leach SD, Toole AL, Stern H, DeNatale RW, Tilson D. Effects 
of~ adrenergic blockade on the growth rate ofabdominal ortic 
aneurysms. Arch Surg 1988;123:ö06-9. 
2. Gadowski GR, Pilcher DB, Ricci MA. bdominal aortic aneu- 
rysm expansion rate: Effect ofsize and beta-adrenergic block- 
ade. J Vase Surg 1994;19:727-31. 
3. Schneiderman J, Bordin GM, Engelberg I, et al. Expression f
fibrinolytic genes in atherosclerotic abdominal ortic aneurysm 
wall. l Clin Invest 1995;96:639-45. 
4. Reitly IM, Sicard GA, Lucore CL. Abnormal expression of 
plasminogen activators in aortic aneurysmal and occlusive 
disease. I Vasc Surg 1994;19:865-72. 
5. Probst A, Lill H, Strein K. Beta-adrenergic receptor mediated 
release of tissue plasminogen activator in anaesthetized dogs. 
Thromb Res 1988;50:9-17. 
6. Zhu GI, Abbadini M, Donati MB, Mussoni L. Tissue type 
plasminogen actävator release in response to epinephrine in 
perfused rat hindlegs. Am I Physio11989;256:H404-10, 
7. Gleerup G, Hedner T, Hjorting Hansen E, Winther K. Does 
antihypertensive therapy affect the natural protection against 
thrombosis? J Cardiovasc Pharmacol 1991;18 suppl 3:$34-6. 
24/41/71934 
Regarding "Percutaneous transluminal a gioplasty 
for emboligenic arterial lesions after radiotherapy of  
axillary arteries" 
To the Editors: 
We are writing in regard to your published article 
entitled "Percutaneous transluminal ngioplasty for embo- 
ligenic arterial lesions after adiotherapy ofaxillary arteries" 
by Veyssier-Belot e  al. (J Vasc Surg 1995;22:118-9). The 
authors have reported the good results of percutaneous 
transluminal ngioplasty (PTA) in these kind oflesions. Our 
experience support these data; moreover, we suggest the use 
of endovascular stenting in the presence of fibrotic degen- 
eration of the arterial wall, often complicated by low-grade 
calcifications. The use of intravascular ultrasound (IVUS) 
for accurate intraoperative monitoring of the endovascular 
treatment ofthese particular arterial lesions is also indicated. 
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Fig. 2. Predilatation IVUS monitoring. 
Fig. 1. Preoperative angiography. 
Fig. 3. Postprocedural IVUS control. 
CASE REPORT 
A 46-year-old woman was admitted in our Institute for 
symptomatic bilateral thigh and leg claudication i Febru- 
ary 1993. Four years earlier she had undergone an anterior 
resection of the rectum for a metastasized a enocarcinoma. 
Fractioned irradiation of the pelvis was administered in an 
adjuvant setting for a total dose of 60 Gy. 
Preoperative angiography (Fig. 1) showed atight steno- 
sis of the external iliac artery on the leff side and an 
obstruction of the external iliac artery on the right side, with 
normal patency of the other egional vessels. Intraoperative 
IVUS confirmed stenosis caused by intimal hyperplasia and 
fibrosis of the media l yer (Fig. 2). 
The patient was submitted to PTA of the leff external 
iliac artery with a 7-mm-x-4-cm Olbert catheter (Meadox 
-Surgimed, Stenlose, Denmark) and subsequent insertion 
of t'wo P304 Palmaz stents (Johnson & Johnson Interven- 
tion Systems Co., Warten, NJ.) .  A left-to-right femoro- 
femoral cross-over bypass was performed in the same 
operative session using a ó-mm polytetrafluoroethylene 
graft. 
The intraoperative IVUS control confirmed the good 
expansion of the stents (Fig. 3). The postoperative course 
was uneventful and the patient was discharged on antiplate- 
ler therapy. 
Six months after surgery the patient is still asymptom- 
atic with normal tibial pulses. Radiation-induced arteriopa- 
thy is an ingravescent chronic lesion involving amyointimal 
hyperplasia and a remarkable fibrosis of the arterial outer 
layers resulting in stenosis and obstruction of the irradiated 
Vessels. 
Based on these findings, we believe that a mechanical 
support, such as an endovascular stent is to be favored to 
prevent the immediate lastie recoil caused by fibrotic 
degeneration a d to contrast the long-time volution ofthis 
inflammatory chronic lesion. 
The proximal and the distal end of the stent must be 
placed on healthy tissuc. The endovascular p ocedures are 
better supported by accurate intraoperative IVUS monitor- 
ing to define the real limits of the lesion and to control 
complete xpansion of the stent. 
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Regarding "Should percutaneous transluminal 
angioplasty be recommended for treatment of  
infrageniculate popliteal artery or tibioperoneal 
trunk stenosis?" 
To ~he Editors: 
We are writing to you about he article by Treiman et al, 
which appeared in the October 1995 issue (J Vasc Surg 
1995;22:457-65). 
